高级搜索

参归丸对顺铂化疗H22荷瘤小鼠的减毒增效作用及其机制

刘永琦, 闫德祺, 李应东, 李 豆, 李静雅, 蔺兴遥, 伍志伟, 颜春鲁

刘永琦, 闫德祺, 李应东, 李 豆, 李静雅, 蔺兴遥, 伍志伟, 颜春鲁. 参归丸对顺铂化疗H22荷瘤小鼠的减毒增效作用及其机制[J]. 肿瘤防治研究, 2014, 41(06): 552-556. DOI: 10.3971/j.issn.1000-8578.2014.06.010
引用本文: 刘永琦, 闫德祺, 李应东, 李 豆, 李静雅, 蔺兴遥, 伍志伟, 颜春鲁. 参归丸对顺铂化疗H22荷瘤小鼠的减毒增效作用及其机制[J]. 肿瘤防治研究, 2014, 41(06): 552-556. DOI: 10.3971/j.issn.1000-8578.2014.06.010
LIU Yongqi, YAN Deqi, Li Yingdong, LI Dou, Li Jingya, Lin Xingyao, Wu Zhiwei, Yan Chunlu. Attenuated and Synergistic Effects of Angelica Sinensis and Radix Sophorae Flavescentis Decoction on H22 Tumor-bearing Mice Treated with Cisplatin and Its Mechanism[J]. Cancer Research on Prevention and Treatment, 2014, 41(06): 552-556. DOI: 10.3971/j.issn.1000-8578.2014.06.010
Citation: LIU Yongqi, YAN Deqi, Li Yingdong, LI Dou, Li Jingya, Lin Xingyao, Wu Zhiwei, Yan Chunlu. Attenuated and Synergistic Effects of Angelica Sinensis and Radix Sophorae Flavescentis Decoction on H22 Tumor-bearing Mice Treated with Cisplatin and Its Mechanism[J]. Cancer Research on Prevention and Treatment, 2014, 41(06): 552-556. DOI: 10.3971/j.issn.1000-8578.2014.06.010

参归丸对顺铂化疗H22荷瘤小鼠的减毒增效作用及其机制

基金项目: 甘肃省高校基本科研业务费基金资助项目(2009-192-3);国家科技支撑计划课题(2011BAI05B02)
详细信息
    作者简介:

    刘永琦(1973-),男,博士,教授,主要从事中西医结合的基础实验研究

    闫德祺(1967-),男,硕士,医师,主要从事生物医药的基础研究(*:并列第一作者)

  • 中图分类号: R730.53;R285

Attenuated and Synergistic Effects of Angelica Sinensis and Radix Sophorae Flavescentis Decoction on H22 Tumor-bearing Mice Treated with Cisplatin and Its Mechanism

  • 摘要: 探讨参归丸的抑瘤作用及对顺铂化疗H22荷瘤小鼠的增效减毒作用。方法 建立小鼠H22肝癌移植瘤模型,随机分为模型组、顺铂组、参归丸组、参归丸加顺铂联合组,另设正常对照组。观察各组小鼠一般状况,计算有效体重变化;检测各给药组的抑瘤率、q值、肿瘤指数、肝脏、脾脏、胸腺、肾脏的器官指数。血常规检测白细胞计数,ELISA检测血清低氧诱导因子(HIF1α)的浓度,血生化检测乳酸脱氢酶(LDH)活力。结果 参归丸组和联合组的一般状况优于模型组和顺铂组;各治疗组的瘤体质量皆小于模型组的瘤体质量( P<0.05),联合组的抑瘤率高于单用参归丸或顺铂组的抑瘤率,联合用药疗效具有相加效应;参归丸组有效体重增加、脾脏和胸腺指数高于顺铂组(P<0.05);参归丸组和联合组血清HIF1α浓度低于模型组( P<0.05);顺铂组血清LDH活性高于其他治疗组( P<0.05)。结论 参归丸具有抑瘤作用和对顺铂化疗的增效减毒作用,其机制可能在一定程度上与降低小鼠血清中HIF1α浓度和LDH活性有关。

     

    Abstract: Abstract:Objective To investigate the inhibitory effect of Angelica sinensis and Radix Sophorae Flavescentis Decoction (ARD) on H22 transplanted tumor and serum HIF1α and LDH in mice. Methods H22 hepatocellular transplantation tumor models were established to be randomly divided into the control, cisplatin, ARD and ARD plus cisplatin groups. General state of KM mice was observed to calculate effective bodyweight changes. Tumor inhibition rate, q value, as well as indexes of tumor, liver, spleen, kidney and thymus were calculated. Blood routine was applied to determine white blood cell count. Serum HIF1α and LDH were determined by ELISA and biochemistry method separately. Results The general states of ARD plus cisplatin group and ARD group were better than those of cisplatin group and control group. The tumor weights of treatment groups were lighter than that of control group( P<0.05). The tumor inhibiting rate of ARD plus cisplatin group was higher than those of ARD group and cisplatin group. ARD plus cisplatin had Synergistic effect. Increase of bodyweight minus tumor weight, and indexes of spleen and thymus in ARD group were higher than those in cisplatin group ( P<0.05). Serum level of HIF-1α in control group was higher than those of ARD group and ARD plus cisplatin group( P<0.05). LDH activity in cisplatin group was higher than those in other treatment groups. ( P<0.05). Conclusion ARD can inhibit the growth of transplanted tumor in mice, provide positive effect and reduce the side effect of cisplatin chemotherapy, which might have the relation with reducing HIF-1α concentration and LDH activity to a certain degree.

     

  • [1] Zhang Z, Wang X, Wu W, et al. Effects of matrine on proliferation and apoptosis in gallbladder carcinoma cells (GBC-SD)[J]. Phytother Res, 2012, 26(6):932-7.
    [2] Jin N, Zhao YX, Deng SH, et al. Preparation and in vitro anticancer activity of oxymatrine mixed micellar nanoparticles[J]. Pharmazie. 2011,66(7):506-10.
    [3] Berghe WV, De Naeyer A, Dijsselbloem N, et al. Attenuation of ERK/RSK2-driven NFκB gene expression and cancer cell proliferation by kurarinone, a lavandulyl fl avanone isolated from Sophora flavescens ait. roots[J]. Endocr Metab Immune Disord Drug Targets, 2011, 11(3):247-61.
    [4] Liu C, Li J, Meng FY, et al. Polysaccharides from the root of Angelica sinensis promotes hematopoiesis and thrombopoiesis through the PI3K/AKT pathway[J]. BMC Complement Altern Med, 2010,10:79.
    [5] Hui MK, Wu WK, Shin VY, et al. Polysaccharides from the root of Angelica sinensis protect bone marrow and gastrointestinal tissues against the cytotoxicity of cyclophosphamide in mice[J]. Int J Med Sci, 2006,3(1): 1-6.
    [6] Zhang MH, Wang XY,Wang XM, et al. Inhibition of Lycium barbarum polysaccharide on transplanted liver cancer in mice[J]. Zhong Cao Yao, 2012,43(6):1142-6.[张鸣号, 王秀玉,王秀梅, 等.枸杞多糖对小鼠移植性肝癌抑制作用的实验研究[J].中草 药, 2012,43(6):1142-6.]
    [7] Ling HY, Gu KS. The effec t of epirubici combined with nimotuzum ab on human hepatocellular carcinoma cell lineHepG2 in vitro[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2011,16(2):113-7.[ 凌华毓, 顾康生. 尼妥珠单抗联合表阿霉素对人肝癌细胞株 HepG2体外生长的影响[J]. 临床肿瘤学杂志, 2011,16(2):113-7.]
    [8] Wang J , Ma SM, Chen XH. Antitumor Efect o f Thalidomide Combined with Cyctlophosphamide and Its Antitumor Mechanism[J].Zhongguo Yi Yao Gong Ye Za Zhi,2011,42 (12): 918. [王娟,马淑梅, 陈秀华. 沙利度胺合并环磷酞胺的抗肿瘤作用 及相关作用机制研究[J]. 中国医药工业杂志,2011,42 (12 ):918.]
    [9] Liang L, Wang XY, Zhang XH, et al. Sophoridine exerts an anticolorectal carcinoma effect through apoptosis induction in vitro and in vivo[J]. Life Sci, 2012,91(25-26):1295-303.
    [10] Zhang Y, Wang S, Li Y, et al. Sophocarpine and matrine inhibit the production of TNF-alpha and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice[J]. Int Immunopharmacol,2008,8(13-14): 17 67-72.
    [11] Drug Administration of Health Ministry o People’s Republic of China. Protocol for the study of Traditional Chinese Medicine and new drugs[M]. Beijing: Drug Administration of Health Ministry o People’s Republic of China, 1994:104.[中华人民共和国卫生部 药政局.中药新药研究指南[M].北京:中华人民共和国卫生部 药政管理局,1994:104.]
    [12] Zhao L, Wang Y, Shen HL, et al. Structural characterization and radioprotection of bone marrow hematopoiesis of two novel polysaccharides from the root of Angelica sinensis (Oliv.) Diels[J]. Fitoterapia,2012, 83(8):1712-20.
    [13] Kitagawa N, Kondo S, Wakisaka N, et al. Expression of seven-inabsentia homologue 1 and hypoxia-inducible factor 1 alpha: novel prognostic factors of nasopharyngeal carcinoma[J]. Cancer Lett, 20 13,331(1):52-7.
    [14] Cheng C, Cai S, Wang G, et al. c-Myc enhances colon cancer cell-mediated angiogenesis through the regulation of HIF-1α[J]. Biochem Biophys Res Commun, 2013, 430(2): 505-11.
    [15] Takala H, Saarnio J, Wiik H, et al. HIF-1α and VEGF are associated with disease progression in esophageal carcinoma[J]. J Surg Res, 2011,167(1): 41-8.
    [16] ZHOU Juan,NI Songshi,BEN Suqin. Effect of matrine on proliferation and HIF-1α,VEGF expression of A549 cells [J]. Shandong Yi Yao, 2012,52(3):25-7.[周娟,倪松石,贲素琴. 苦参碱 对人肺腺癌A549 细胞增殖及HIF-1α、VEGF 表达的影响[J]. 山东医药,2012,52(3):25-7.]
    [17] Nishihara K, Masuda S, Shinke H, et al. Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity[J]. Biochem Pharmacol, 2013, 85(4): 570-82.
    [18] Cangemi G, Reggiardo G, Barco S, et al. Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma[J]. Onco Targets Ther,2012, 5: 417-23.
    [19] Chen F,Huang K. Effects of the Chinese medicine matrine on experimental C. parvum infection in BALB/c mice and MDBK cells[J]. Parasitol Res,2012, 111(4):1827-32.
    [20] Demkow U, Stelmaszczyk-Emmel A. Cardiotoxicity of cisplatinbased chemotherapy in advanced non-small cell lung cancer patients[J]. Respir Physiol Neurobiol,2013, 187(1): 64-7.
    [21] Azu OO, Duru FIO, Osinubi AA, et al. Histomorphometric effects of Kigelia africana (Bignoniaceae) fruit extract on the testis following short-term treatment with cisplatin in male Sprague- Dawley rats[J]. Middle East Fertil Soc J, 2010,15(3): 200-8.
    [22] Mohamed HE, El-Swefy SE, Mohamed RH, et al. Effect of erythropoietin therapy on the progression of cisplatin induced renal injury in rats[J]. Exp Toxicol Pathol, 2013,65(1-2): 197-203.
    [23] Rezvanfar MA, Rezvanfar MA, Shahverdi AR, et al. Protection of cisplatin-induced spermatotoxicity, DNA damage and chromatin abnormality by selenium nano-particles[J]. Toxicol Appl Pharmacol, 2013, 266(3): 356-65.
    [24] Gopal KV, Wu C, Shrestha B, et al. d-Methionine protects against cisplatin-induced neurotoxicity in cortical networks[J]. Neurotoxicol Teratol, 2012,34(5): 495-504.
    [25] Qu J, Li X, Wang J, et al. Inhalation of hydrogen gas attenuates cisplatin-induced ototoxicity via reducing oxidative stress[J]. Int J Pediatr Otorhinolaryngol,2012,76(1): 111-5.
    [26] Rjiba-Touati K, Ayed-Boussema I, Skhiri H, et al. Induction of DNA fragmentation, chromosome aberrations and micronuclei by cisplatin in rat bone-marrow cells: protective effect of recombinant human erythropoietin[J]. Mutat Res, 2012,747(2): 20 2-6.
    [27] Nessa MU, Beale P, Chan C, et al. Studies on combination of platinum drugs cisplatin and oxaliplatin with phytochemicals anethole and curcumin in ovarian tumour models[J]. Anticancer Res, 2012, 32(11):4843-50.
计量
  • 文章访问数:  1199
  • HTML全文浏览量:  363
  • PDF下载量:  623
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-06-29
  • 修回日期:  2013-11-06
  • 刊出日期:  2014-06-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭